Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration

Researchers have developed a new wireless technology that could offer a path toward restoring vision for individuals with retinal degenerative diseases. The innovation, stemming from a team led by Prof. Dr. Sedat Nizamoğlu at Koç University, centers around a nanoscale system designed to convert light into electrical signals within the eye.

A New Approach to Vision Loss

Retinal degenerative disorders impact millions globally, and currently, there are no cures. Existing retinal implants have faced hurdles due to their size, complexity, and reliance on potentially harmful high-intensity visible light. This new technology aims to overcome these limitations with an ultra-thin, biocompatible design.

How It Works

The system utilizes a “photovoltaic nano-assembly” – a combination of zinc oxide nanowire arrays and silver-bismuth-sulfide nanocrystals. This structure converts near-infrared light, which is safer and penetrates tissue more effectively than visible light, into precisely controlled electrical stimulation. The process operates at low light intensities, remaining within established safety limits, and is entirely wireless.

Did You Know? Inorganic nanocrystals, a key component of this technology, were recognized with the 2023 Nobel Prize in Chemistry.

Testing on retinal models from rats with vision loss showed strong, repeatable, and precise responses in retinal neurons. Further analysis confirmed the structure’s biocompatibility and long-term stability, with no evidence of cellular stress or toxicity. Temperature increases during operation were negligible, further supporting the safety profile.

Beyond Vision

The technology’s unique features – its ultra-thin design, use of near-infrared light, and wireless operation – distinguish it from current retinal implants. Researchers suggest it could have applications beyond visual prostheses, potentially impacting neuromodulation of other electrically excitable tissues like the brain, heart, and muscles.

Expert Insight: The development of a fully wireless, nanoscale retinal implant represents a significant shift in the field, potentially addressing key limitations of existing technologies and opening doors to broader applications in the nervous system.

According to Prof. Dr. Sedat Nizamoğlu, the research demonstrates the potential of a nanotechnological approach to restore vision in individuals with macular degeneration and retinitis pigmentosa. He also noted the findings create new possibilities for biomedical applications interacting with the nervous system.

Frequently Asked Questions

What types of retinal disorders could this technology potentially address?

This technology could potentially restore vision in individuals who have lost visual function due to macular degeneration and retinitis pigmentosa.

What makes this technology safer than existing retinal implants?

This technology uses safer near-infrared light instead of visible light and operates at low light intensities that remain below established ocular safety limits. It also has a fully wireless, ultra-thin architecture.

Was this technology tested on humans?

The performance of the system was evaluated using retinal models from rats with vision loss.

Could this innovative approach to retinal stimulation pave the way for a future where vision loss is no longer an insurmountable challenge?